Please enable JavaScript to continue using this application.

Compare $EIKN vs $KYTX | Chartloom

Compare

$EIKN vs $KYTX

Eikon Therapeutics Inc · Kyverna Therapeutics Inc

EIKN

Eikon Therapeutics Inc

KYTX

Kyverna Therapeutics Inc

Compare $EIKN vs $KYTX

Comparing Eikon Therapeutics Inc and Kyverna Therapeutics Inc

EIKNEikon Therapeutics Inc

KYTXKyverna Therapeutics Inc

EIKNEikon Therapeutics Inc

Market cap

$404M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-50.2%

52W performance

-50.2%

FCF yield

-96.6%

KYTXKyverna Therapeutics Inc

Market cap

$389M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-27.1%

52W performance

-11.0%

FCF yield

-41.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EIKN

KYTX

Detailed metrics comparison

EIKN

Eikon Therapeutics Inc

KYTX

Kyverna Therapeutics Inc

Market Cap

EIKN$404M

KYTX$389M

Enterprise Value

EIKN$262M

KYTX$382M

Price

EIKN$7.47

KYTX$6.39

P/E Ratio

EIKNN/A

KYTXN/A

P/S Ratio

EIKN0.00x

KYTX0.00x

EV/Sales

EIKN0.00x

KYTX0.00x

EV/EBITDA

EIKN0.00x

KYTX0.00x

P/B Ratio

EIKN0.85x

KYTX2.32x

P/FCF Ratio

EIKNN/A

KYTXN/A

EV/FCF

EIKN-0.67x

KYTX-2.38x

PEG Ratio

EIKN0.00x

KYTXN/A

Forward P/E (NTM)

EIKNN/A

KYTXN/A

Forward P/S (NTM)

EIKNN/A

KYTXN/A

Revenue (TTM)

EIKN$0

KYTX$0

Revenue Growth (YoY)

EIKNN/A

KYTXN/A

Forward Rev Growth

EIKN436.8%

KYTX252.6%

Gross Margin (TTM)

EIKN0.0%

KYTX0.0%

Operating Margin (TTM)

EIKN0.0%

KYTX0.0%

EBITDA Margin (TTM)

EIKN0.0%

KYTX0.0%

Net Margin (TTM)

EIKN0.0%

KYTX0.0%

FCF Margin (TTM)

EIKNN/A

KYTXN/A

Net Income (TTM)

EIKN$-505M

KYTX$-153M

FCF (TTM)

EIKN$-391M

KYTX$-160M

EPS (TTM)

EIKN-$9.33

KYTX-$2.51

ROE (TTM)

EIKN-11966.0%

KYTX-8191.0%

ROA (TTM)

EIKN-6914.0%

KYTX-6374.0%

ROIC (TTM)

EIKN-11966.0%

KYTX-7440.0%

Cash

EIKN$143M

KYTX$32M

Debt

EIKN$0

KYTX$25M

Net Cash/Debt

EIKN$143M

KYTX$7M

Current Ratio (TTM)

EIKN9.89x

KYTX9.06x

Quick Ratio (TTM)

EIKN9.61x

KYTX8.75x

Debt/Equity (TTM)

EIKN0.00x

KYTX0.15x

Debt/Assets (TTM)

EIKN0.0%

KYTX0.0%

Interest Coverage (TTM)

EIKNN/A

KYTXN/A

Net Debt/EBITDA (TTM)

EIKN0.00x

KYTX0.00x

Beta

EIKN1.90

KYTX2.11

52W Performance

EIKN-50.2%

KYTX-11.0%

YTD Performance

EIKN-50.2%

KYTX-27.1%

% from 52W High

EIKN-57.1%

KYTX-53.3%

% from 52W Low

EIKN6.5%

KYTX7.2%

Asset Turnover (TTM)

EIKN0.00x

KYTX0.00x

FCF Yield (TTM)

EIKN-96.6%

KYTX-41.2%

Earnings Yield (TTM)

EIKN-124.9%

KYTX-39.3%

Dividend Yield (TTM)

EIKNN/A

KYTXN/A

Rule of 40

EIKN0.0

KYTX0.0

EV/GP/RG

EIKNN/A

KYTXN/A

Ticker research

View EIKN research View KYTX research

Metric	EIKN Eikon Therapeutics Inc	KYTX Kyverna Therapeutics Inc
Market & Valuation
Market Cap	$404M	$389M
Enterprise Value	$262M	$382M
Price	$7.47	$6.39
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	2.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-2.38x
PEG Ratio	0.00x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	436.8%	252.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-505M	$-153M
FCF (TTM)	$-391M	$-160M
EPS (TTM)	-$9.33	-$2.51
ROE (TTM)	-11966.0%	-8191.0%
ROA (TTM)	-6914.0%	-6374.0%
ROIC (TTM)	-11966.0%	-7440.0%
Financial Health
Cash	$143M	$32M
Debt	$0	$25M
Net Cash/Debt	$143M	$7M
Current Ratio (TTM)	9.89x	9.06x
Quick Ratio (TTM)	9.61x	8.75x
Debt/Equity (TTM)	0.00x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.90	2.11
52W Performance	-50.2%	-11.0%
YTD Performance	-50.2%	-27.1%
% from 52W High	-57.1%	-53.3%
% from 52W Low	6.5%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-96.6%	-41.2%
Earnings Yield (TTM)	-124.9%	-39.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EIKN research	View KYTX research

Valuation

P/S Ratio

EIKN

0.00x

KYTX

0.00x

EV/FCF

KYTX

-2.38x

EIKN

-0.67x

Growth & revenue

Forward Revenue Growth

EIKN

436.8%

KYTX

252.6%

Profitability & performance

Gross Margin

EIKN

0.0%

KYTX

0.0%

ROE

KYTX

-8191.0%

EIKN

-11966.0%

FCF Yield %

KYTX

-41.2%

EIKN

-96.6%

52-Week Performance

KYTX

-11.0%

EIKN

-50.2%

Detailed metrics comparison

EIKN

Eikon Therapeutics Inc

KYTX

Kyverna Therapeutics Inc

Market Cap

EIKN$404M

KYTX$389M

Enterprise Value

EIKN$262M

KYTX$382M

Price

EIKN$7.47

KYTX$6.39

P/E Ratio

EIKNN/A

KYTXN/A

P/S Ratio

EIKN0.00x

KYTX0.00x

EV/Sales

EIKN0.00x

KYTX0.00x

EV/EBITDA

EIKN0.00x

KYTX0.00x

P/B Ratio

EIKN0.85x

KYTX2.32x

P/FCF Ratio

EIKNN/A

KYTXN/A

EV/FCF

EIKN-0.67x

KYTX-2.38x

PEG Ratio

EIKN0.00x

KYTXN/A

Forward P/E (NTM)

EIKNN/A

KYTXN/A

Forward P/S (NTM)

EIKNN/A

KYTXN/A

Revenue (TTM)

EIKN$0

KYTX$0

Revenue Growth (YoY)

EIKNN/A

KYTXN/A

Forward Rev Growth

EIKN436.8%

KYTX252.6%

Gross Margin (TTM)

EIKN0.0%

KYTX0.0%

Operating Margin (TTM)

EIKN0.0%

KYTX0.0%

EBITDA Margin (TTM)

EIKN0.0%

KYTX0.0%

Net Margin (TTM)

EIKN0.0%

KYTX0.0%

FCF Margin (TTM)

EIKNN/A

KYTXN/A

Net Income (TTM)

EIKN$-505M

KYTX$-153M

FCF (TTM)

EIKN$-391M

KYTX$-160M

EPS (TTM)

EIKN-$9.33

KYTX-$2.51

ROE (TTM)

EIKN-11966.0%

KYTX-8191.0%

ROA (TTM)

EIKN-6914.0%

KYTX-6374.0%

ROIC (TTM)

EIKN-11966.0%

KYTX-7440.0%

Cash

EIKN$143M

KYTX$32M

Debt

EIKN$0

KYTX$25M

Net Cash/Debt

EIKN$143M

KYTX$7M

Current Ratio (TTM)

EIKN9.89x

KYTX9.06x

Quick Ratio (TTM)

EIKN9.61x

KYTX8.75x

Debt/Equity (TTM)

EIKN0.00x

KYTX0.15x

Debt/Assets (TTM)

EIKN0.0%

KYTX0.0%

Interest Coverage (TTM)

EIKNN/A

KYTXN/A

Net Debt/EBITDA (TTM)

EIKN0.00x

KYTX0.00x

Beta

EIKN1.90

KYTX2.11

52W Performance

EIKN-50.2%

KYTX-11.0%

YTD Performance

EIKN-50.2%

KYTX-27.1%

% from 52W High

EIKN-57.1%

KYTX-53.3%

% from 52W Low

EIKN6.5%

KYTX7.2%

Asset Turnover (TTM)

EIKN0.00x

KYTX0.00x

FCF Yield (TTM)

EIKN-96.6%

KYTX-41.2%

Earnings Yield (TTM)

EIKN-124.9%

KYTX-39.3%

Dividend Yield (TTM)

EIKNN/A

KYTXN/A

Rule of 40

EIKN0.0

KYTX0.0

EV/GP/RG

EIKNN/A

KYTXN/A

Ticker research

View EIKN research View KYTX research

Metric	EIKN Eikon Therapeutics Inc	KYTX Kyverna Therapeutics Inc
Market & Valuation
Market Cap	$404M	$389M
Enterprise Value	$262M	$382M
Price	$7.47	$6.39
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	2.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-2.38x
PEG Ratio	0.00x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	436.8%	252.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-505M	$-153M
FCF (TTM)	$-391M	$-160M
EPS (TTM)	-$9.33	-$2.51
ROE (TTM)	-11966.0%	-8191.0%
ROA (TTM)	-6914.0%	-6374.0%
ROIC (TTM)	-11966.0%	-7440.0%
Financial Health
Cash	$143M	$32M
Debt	$0	$25M
Net Cash/Debt	$143M	$7M
Current Ratio (TTM)	9.89x	9.06x
Quick Ratio (TTM)	9.61x	8.75x
Debt/Equity (TTM)	0.00x	0.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.90	2.11
52W Performance	-50.2%	-11.0%
YTD Performance	-50.2%	-27.1%
% from 52W High	-57.1%	-53.3%
% from 52W Low	6.5%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-96.6%	-41.2%
Earnings Yield (TTM)	-124.9%	-39.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EIKN research	View KYTX research